Financials in USD. Standardized financial statements.
A compact view of how AVVAA World Health Care Products, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2007 | FY 2006 | FY 2005 | FY 2004 | FY 2003 | FY 2002 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $4,650 | $0 | $2,000 | $0 | $95,577 | $18,657 | $13,021 | $9,409 | $0 | $0 |
| Revenue Growth? | 0.0% | -100.0% | 0.0% | -100.0% | +412.3% | +43.3% | +38.4% | 0.0% | 0.0% | 0.0% |
| Cost of Revenue? | $3,129 | $0 | $9,763 | $0 | $444,096 | $34,719 | $6,277 | $6,204 | $0 | $0 |
| Gross Profit? | $1,521 | $0 | -$7,763 | $0 | -$348,519 | -$16,062 | $6,744 | $3,205 | $0 | $0 |
| Gross Margin? | +32.7% | 0.0% | -388.1% | 0.0% | -364.6% | -86.1% | +51.8% | +34.1% | 0.0% | 0.0% |
| Operating Expenses? | $36,245 | $42,751 | $77,257 | $28,974 | $2.82M | $2.62M | $2.84M | $2.15M | $810,363 | $81,596 |
| Operating Income? | -$34,724 | -$42,751 | -$75,257 | -$28,974 | $3.16M | $2.64M | $2.83M | $2.14M | $810,363 | $81,596 |
| EBITDA? | -$34,724 | -$42,751 | -$75,257 | -$28,974 | -$2.01M | -$1.27M | -$1.19M | -$1.19M | -$808,977 | -$200,553 |
| Income Before Tax | -$39,123 | -$42,751 | -$75,257 | -$28,974 | $3.18M | $2.47M | $2.61M | $2.07M | $0 | $201,385 |
| Income Tax Expense | $0 | $0 | $0 | $0 | $1.31M | $1.40M | $316,338 | $86,163 | $9,245 | -$119,185 |
| Net Income? | -$39,123 | -$42,751 | -$75,257 | -$28,974 | -$4.47M | -$4.04M | -$3.15M | -$2.23M | -$819,608 | $37,589 |
| EPS? | $0.00 | $0.00 | $-0.00 | $0.00 | $-3.27 | $-9.52 | $-11.45 | $-11.07 | $-6.58 | $1.00 |
| Diluted EPS? | $0.00 | $0.00 | $-0.00 | $0.00 | $-3.27 | $-9.52 | $-11.45 | $-11.07 | $-6.58 | $1.00 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality